July 23, 2014 3:34 AM ET

Healthcare Equipment and Supplies

Company Overview of Cadence Biomedical, Inc.

Company Overview

Empowering Engineering Technologies, Inc. manufactures and distributes ExoWalk, an elastic tendon-like medical device that helps people with gait disabilities walk. The company was incorporated in 2007 and is based in Seattle, Washington.

146 North Canal Street

Suite 100

Seattle, WA 98103-8136

United States

Founded in 2007

Phone:

414-807-7399

Key Executives for Cadence Biomedical, Inc.

President
Compensation as of Fiscal Year 2014.

Cadence Biomedical, Inc. Key Developments

Cadence Biomedical, Inc. Launches Kickstart Kinetic Orthosis

Cadence Biomedical, Inc. announced the launch and commercial availability of its first product, the Kickstart(TM) Kinetic Orthosis. Kickstart is a wearable device that can help individuals with weakened muscles or disabilities regain mobility and independence. Following a pilot program that was well received by physical therapists, orthotists, and users, Kickstart is now available commercially in the United States. Kickstart uniquely stores and releases a user's own energy to provide walking assistance, improve stability, and enhance physical therapy for those recovering from strokes, partial spinal cord injuries, and other conditions that affect mobility. Unlike robotic devices, there are no batteries, motors, or noises associated with its use. Kickstart was inspired by the anatomy of horses, whose long tendons span multiple joints and allow for highly efficient walking and running. Kickstart is designed to bring new levels of function for those who have plateaued in therapy, and also open new opportunities for supporting recovery and an enhanced quality of life. A growing body of clinical data speaks to its benefits, including case studies presented at this year's annual meetings of the American Academy of Orthotists and Prosthetists (AAOP) and the American Orthotic and Prosthetic Association (AOPA), in which Kickstart users were able to walk considerably farther and faster while using the device. Cadence is conducting clinical studies aimed at further quantifying Kickstart's benefits with partner academic institutions and expects to begin reporting data in 2013. Kickstart is specifically intended for individuals with lower extremity weakness -- particularly in the hip flexors and ankle plantarflexors -- and poor endurance, secondary to neurological injury or disease such as stroke, incomplete spinal cord injury, ALS, muscular dystrophy and multiple sclerosis. The device is worn over clothing, and unilateral and bilateral configurations are available. Kickstart is prescribed by a physician and custom-fit by an orthotist.

Similar Private Companies By Industry

Company Name Region
Nuclear Resources, Inc. United States
Timely Medical Innovations, LLC United States
Cardialen, Inc. United States
Elastic Therapy, Inc. United States
Burpee Materials Technology L.L.C. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cadence Biomedical, Inc., please visit www.eetechcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.